Identification and quantification of biomolecules using advanced mass spectrometry techniques
The Proteomics Platform is one of the Centre for Translational Biology (CTB) Technology Platforms at the Research Institute of the McGill University Health Centre (RI-MUHC). It specializes in identifying and quantifying proteins, using advanced mass spectrometry techniques to detect biomolecular changes in health and disease for biomedical and clinical applications.
The Proteomics Platform staff have extensive experience in high resolution–quantitative proteomics, advanced bioinformatics, and mapping quantitative proteomics data onto biological pathways.
Applications and services
The Proteomics Platform performs:
Additional services relate to:
Small molecule analysis
The Proteomics Platform provides services to analyze and quantify peptides, steroids, neurotransmitters, cannabinoids, endocannabinoids, amino acids, prostaglandins and many other “small” molecules.
Platform staff can also help you design new assays to measure almost any biomolecule, often in a multiplexed assay to help keep costs down. The platform offers expertise in planning, designing and executing studies, data analysis and training.
The platform offers fee-for-service ELISA using commercially available plates for the costs of the plates + including duplicate measurements + standard curves + controls. ELISA data are reported in a comprehensive fashion with a simple overview of results combined with backup of raw data, extrapolated amounts and controls.
— Marie-Claude Battista, PhD, Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Centre for Translational Biology Technology Platforms
The CTB Technology Platforms provide access to state-of-the-art technologies and instrumentation as well as top-level scientific expertise and training. Watch the video, explore the links below, and prepare to accelerate your research!